Hyram Yarbro sat down with Shelly Sood of GIOSTAR Chicago for an in-depth discussion about the meaning of clean beauty and which companies are engaging in sustainable action within the skincare industry!
Hyram Yarbro sat down with Shelly Sood of GIOSTAR Chicago for an in-depth discussion about how everyone from teenagers to middle-aged women should be re-examining what they think about skin care as well Hyram’s simple but effective basic skincare routine!
Hyram Yarbro sat down with Shelly Sood of GIOSTAR Chicago for an in-depth discussion on how Covid-19 has affected the skincare marketplace and consumer habits!
Hyram Yarbro sat down with Shelly Sood of GIOSTAR Chicago for an in-depth discussion about the skin care industry and the importance of the ingredients in the products that are being sold!
Chronic liver disorders (CLDs) affect roughly 844 million people worldwide, and result in the deaths of about two million people each year. GIOSTAR recently conducted research pointing to the potential benefit of stem cell therapy in addressing this epidemic.
Stem cell therapy has applications that extend beyond traditional disorders (i.e., orthopedic injuries), including skin care. In this blog post, we review the potential benefits of stem cells on wrinkles, acne, psoriasis, and other conditions, and clear up common misconceptions.
Are you suffering from neuropathy? Stem cell therapy is showing promise as a solution for neuropathic pain. Learn more here.
Scientific Review: Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients
GIOSTAR leaders recently wrote on the potential benefits of stem cells in combating COVID-19. Published in Stem Cell Reviews and Reports, the review was written by Drs. Anand Srivastava, Prabhat Soni, Diana Esquivel, Rangnath Mishra, Rajasekar Seetharaman, and Anjum Mahmood
GIOSTAR recently treated a patient suffering from COVID-19 with stem cells. He experienced considerable improvement following this procedure. A placebo-controlled, double-blind study would be needed to better understand the measurable outcome of stem cell treatment for COVID-19.